PRA and PRB expressions, independently of estrogen-dependent signaling, impact 200 distinct genes known to be involved in breast cancer and/or metastasis, from which 90 are regulated in unfavorable direction, with a predominant role of PRA. The gene discussed is S100A6; the disease is breast carcinoma.